Jazz Pharmaceuticals plc

JAZZ

$248.24

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $15,934,290,944.00

EPSttm : 3.38

Jazz Pharmaceuticals plc

$248.24

1.14%

$2.81

JAZZ — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.51

Margin Of Safety %

Put/Call OI Ratio

0.61

EPS Next Q Diff

10.96

EPS Last/This Y

6.56

EPS This/Next Y

11.05

Price

245.54

Target Price

299.24

Analyst Recom

1.42

Performance Q

-1.41

Upside

-57.9%

Beta

0.36

Ticker: JAZZ

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	JAZZ	216.78	0.54	1.83	4295
2026-10-13	JAZZ	210.38	0.53	0.32	4265
2026-10-14	JAZZ	209.68	0.40	0.30	3992
2026-10-15	JAZZ	214.38	0.36	0.01	3968
2026-10-16	JAZZ	210.25	0.31	0.04	4487
2026-10-19	JAZZ	208.42	0.40	1.71	3669
2026-10-20	JAZZ	213.68	0.41	0.64	3706
2026-10-21	JAZZ	211.73	0.41	0.01	3720
2026-10-22	JAZZ	214.61	0.39	0.00	3879
2026-10-23	JAZZ	213.97	0.19	0.01	6922
2026-10-26	JAZZ	205.63	0.19	0.02	6753
2026-10-27	JAZZ	206.78	0.19	0.02	6680
2026-10-28	JAZZ	205.03	0.19	1.00	6743
2026-10-29	JAZZ	207.73	0.19	0.30	6757
2026-10-30	JAZZ	215.99	0.19	65.66	6761
2026-11-02	JAZZ	214.72	0.89	0.41	10793
2026-11-03	JAZZ	229.77	0.89	4.58	11314
2026-11-04	JAZZ	234.63	0.61	0.41	10030
2026-11-05	JAZZ	227.35	0.61	0.14	10034
2026-11-06	JAZZ	234.68	0.61	0.25	10044
2026-11-09	JAZZ	243.56	0.61	0.04	10052
2026-11-10	JAZZ	245.46	0.61	0.19	10036
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	JAZZ	216.82	-41.1	358.2	23.27
2026-10-13	JAZZ	210.21	-41.1	333.2	23.27
2026-10-14	JAZZ	209.81	-62.6	363.3	21.56
2026-10-15	JAZZ	214.45	-62.6	387.3	21.56
2026-10-16	JAZZ	210.20	-62.6	344.6	21.56
2026-10-19	JAZZ	208.40	-62.6	357.0	21.56
2026-10-20	JAZZ	208.40	-62.6	357.0	21.56
2026-10-21	JAZZ	213.64	-68.5	393.6	21.12
2026-10-22	JAZZ	214.59	-71.2	380.5	20.50
2026-10-23	JAZZ	213.90	-71.2	362.8	20.50
2026-10-26	JAZZ	205.64	-75.8	323.8	20.50
2026-10-27	JAZZ	206.79	-75.8	372.4	20.50
2026-10-28	JAZZ	205.03	-75.8	357.1	20.50
2026-10-29	JAZZ	207.82	-75.8	381.3	20.50
2026-10-30	JAZZ	216.18	-88.3	410.5	19.49
2026-11-02	JAZZ	214.46	-88.3	358.6	19.49
2026-11-03	JAZZ	229.93	-100.0	907.8	15.63
2026-11-04	JAZZ	234.57	-1.3	858.9	15.49
2026-11-05	JAZZ	227.29	-1.3	803.7	15.49
2026-11-06	JAZZ	234.68	-100.0	872.2	14.94
2026-11-09	JAZZ	243.54	-100.0	877.2	14.94
2026-11-10	JAZZ	245.54	-100.0	846.0	14.94
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	JAZZ	-4.94	-1.79	8.79
2026-10-13	JAZZ	-4.95	-1.79	8.79
2026-10-14	JAZZ	-4.95	-1.79	8.79
2026-10-15	JAZZ	-4.95	-1.79	8.79
2026-10-16	JAZZ	-4.95	-1.79	8.79
2026-10-19	JAZZ	-4.95	-1.81	8.79
2026-10-20	JAZZ	-4.95	-1.81	8.79
2026-10-21	JAZZ	-4.95	-1.81	8.79
2026-10-22	JAZZ	-4.95	-1.81	8.79
2026-10-23	JAZZ	-4.95	-1.81	8.79
2026-10-26	JAZZ	-4.95	-1.28	8.79
2026-10-27	JAZZ	-4.95	-1.28	9.40
2026-10-28	JAZZ	-4.95	-1.28	9.40
2026-10-29	JAZZ	-4.95	-1.28	9.40
2026-10-30	JAZZ	-4.95	-1.28	9.40
2026-11-02	JAZZ	-4.95	-0.59	9.40
2026-11-03	JAZZ	-4.95	-0.59	9.40
2026-11-05	JAZZ	-5.22	-0.59	9.51
2026-11-06	JAZZ	-5.04	-0.59	9.51
2026-11-09	JAZZ	-5.09	-0.35	9.51
2026-11-10	JAZZ	-5.09	-0.35	9.51
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-4.83

Avg. EPS Est. Current Quarter

6.56

Avg. EPS Est. Next Quarter

6.13

Insider Transactions

-5.09

Institutional Transactions

-0.35

Beta

0.36

Average Sales Estimate Current Quarter

1243

Average Sales Estimate Next Quarter

1140

Fair Value

312.39

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

7.8

Max Drawdown 5-Year %

-42

Target Price

299.24

P/E

83.25

Forward P/E

9.22

PEG

0.19

P/S

3.34

P/B

3.75

P/Free Cash Flow

9.71

EPS

2.95

Average EPS Est. Cur. Y

14.94

EPS Next Y. (Est.)

25.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.37

Relative Volume

0.65

Return on Equity vs Sector %

-21.4

Return on Equity vs Industry %

-1.7

EPS 1 7Days Diff

-0.8

EPS 1 30Days Diff

-3.21

EBIT Estimation

846

◆ JAZZ Healthcare

$245.43

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

20/20

Pullback

6/25

Volume

6/15

Valuation

15/20

TP/AR

5/10

Options

7/10

RSI

66.5

Range 1M

99.9%

Sup Dist

3.2%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

23/25

Growth

22/30

Estimates

9/20

Inst/Vol

1/15

Options

6/10

EPS Yr

78.7%

EPS NY

77.7%

52W%

84%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +147.9% upside

Quality

9/30

Valuation

25/30

Growth

19/25

Stability

3/10

LT Trend

4/5

Upside

+147.9%

Quality

MoS

27%

JAZZ — P/E HistoricalBiotechnology

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2890

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Modeyso for the treatment of diffuse midline glioma harboring an H3 K27M mutation; and Defitelio to treat severe veno-occlusive disease. It also develops Zanidatamab in Phase 3 trial to treat HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC); Dordaviprone to treat H3 K27M-mutant diffuse glioma; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. In addition, the company is developing Zanidatamab to treat neoadjuvant and adjuvant breast cancer; Vyxeos for the treatment of High-risk MDS, newly diagnosed untreated patients with high-risk AML, and De novo intermediate or adverse risk AML stratified by genomics; and JZP3507 to treat pheochromocytoma and paraganglioma that are in Phase 2 clinical trials. Further, it develops JZP815 to treat Raf and Ras mutant tumors; JZP898 for the IFN INDUKIN molecule in solid tumors; and JZP047 to treat absence epilepsy that are in Phase 1 clinical trials. The company collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., Werewolf Therapeutics, Inc; and AbCellera Biologics Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.

JAZZ

Latest News

—

Caricamento notizie per JAZZ…

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Jazz Pharmaceuticals plc

JAZZ

$248.24

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $15,934,290,944.00

EPSttm : 3.38

Jazz Pharmaceuticals plc

$248.24

1.14%

$2.81

JAZZ — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.51

Margin Of Safety %

Put/Call OI Ratio

0.61

EPS Next Q Diff

10.96

EPS Last/This Y

6.56

EPS This/Next Y

11.05

Price

245.54

Target Price

299.24

Analyst Recom

1.42

Performance Q

-1.41

Upside

-57.9%

Beta

0.36

Ticker: JAZZ

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	JAZZ	216.78	0.54	1.83	4295
2026-10-13	JAZZ	210.38	0.53	0.32	4265
2026-10-14	JAZZ	209.68	0.40	0.30	3992
2026-10-15	JAZZ	214.38	0.36	0.01	3968
2026-10-16	JAZZ	210.25	0.31	0.04	4487
2026-10-19	JAZZ	208.42	0.40	1.71	3669
2026-10-20	JAZZ	213.68	0.41	0.64	3706
2026-10-21	JAZZ	211.73	0.41	0.01	3720
2026-10-22	JAZZ	214.61	0.39	0.00	3879
2026-10-23	JAZZ	213.97	0.19	0.01	6922
2026-10-26	JAZZ	205.63	0.19	0.02	6753
2026-10-27	JAZZ	206.78	0.19	0.02	6680
2026-10-28	JAZZ	205.03	0.19	1.00	6743
2026-10-29	JAZZ	207.73	0.19	0.30	6757
2026-10-30	JAZZ	215.99	0.19	65.66	6761
2026-11-02	JAZZ	214.72	0.89	0.41	10793
2026-11-03	JAZZ	229.77	0.89	4.58	11314
2026-11-04	JAZZ	234.63	0.61	0.41	10030
2026-11-05	JAZZ	227.35	0.61	0.14	10034
2026-11-06	JAZZ	234.68	0.61	0.25	10044
2026-11-09	JAZZ	243.56	0.61	0.04	10052
2026-11-10	JAZZ	245.46	0.61	0.19	10036
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	JAZZ	216.82	-41.1	358.2	23.27
2026-10-13	JAZZ	210.21	-41.1	333.2	23.27
2026-10-14	JAZZ	209.81	-62.6	363.3	21.56
2026-10-15	JAZZ	214.45	-62.6	387.3	21.56
2026-10-16	JAZZ	210.20	-62.6	344.6	21.56
2026-10-19	JAZZ	208.40	-62.6	357.0	21.56
2026-10-20	JAZZ	208.40	-62.6	357.0	21.56
2026-10-21	JAZZ	213.64	-68.5	393.6	21.12
2026-10-22	JAZZ	214.59	-71.2	380.5	20.50
2026-10-23	JAZZ	213.90	-71.2	362.8	20.50
2026-10-26	JAZZ	205.64	-75.8	323.8	20.50
2026-10-27	JAZZ	206.79	-75.8	372.4	20.50
2026-10-28	JAZZ	205.03	-75.8	357.1	20.50
2026-10-29	JAZZ	207.82	-75.8	381.3	20.50
2026-10-30	JAZZ	216.18	-88.3	410.5	19.49
2026-11-02	JAZZ	214.46	-88.3	358.6	19.49
2026-11-03	JAZZ	229.93	-100.0	907.8	15.63
2026-11-04	JAZZ	234.57	-1.3	858.9	15.49
2026-11-05	JAZZ	227.29	-1.3	803.7	15.49
2026-11-06	JAZZ	234.68	-100.0	872.2	14.94
2026-11-09	JAZZ	243.54	-100.0	877.2	14.94
2026-11-10	JAZZ	245.54	-100.0	846.0	14.94
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	JAZZ	-4.94	-1.79	8.79
2026-10-13	JAZZ	-4.95	-1.79	8.79
2026-10-14	JAZZ	-4.95	-1.79	8.79
2026-10-15	JAZZ	-4.95	-1.79	8.79
2026-10-16	JAZZ	-4.95	-1.79	8.79
2026-10-19	JAZZ	-4.95	-1.81	8.79
2026-10-20	JAZZ	-4.95	-1.81	8.79
2026-10-21	JAZZ	-4.95	-1.81	8.79
2026-10-22	JAZZ	-4.95	-1.81	8.79
2026-10-23	JAZZ	-4.95	-1.81	8.79
2026-10-26	JAZZ	-4.95	-1.28	8.79
2026-10-27	JAZZ	-4.95	-1.28	9.40
2026-10-28	JAZZ	-4.95	-1.28	9.40
2026-10-29	JAZZ	-4.95	-1.28	9.40
2026-10-30	JAZZ	-4.95	-1.28	9.40
2026-11-02	JAZZ	-4.95	-0.59	9.40
2026-11-03	JAZZ	-4.95	-0.59	9.40
2026-11-05	JAZZ	-5.22	-0.59	9.51
2026-11-06	JAZZ	-5.04	-0.59	9.51
2026-11-09	JAZZ	-5.09	-0.35	9.51
2026-11-10	JAZZ	-5.09	-0.35	9.51
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-4.83

Avg. EPS Est. Current Quarter

6.56

Avg. EPS Est. Next Quarter

6.13

Insider Transactions

-5.09

Institutional Transactions

-0.35

Beta

0.36

Average Sales Estimate Current Quarter

1243

Average Sales Estimate Next Quarter

1140

Fair Value

312.39

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

7.8

Max Drawdown 5-Year %

-42

Target Price

299.24

P/E

83.25

Forward P/E

9.22

PEG

0.19

P/S

3.34

P/B

3.75

P/Free Cash Flow

9.71

EPS

2.95

Average EPS Est. Cur. Y

14.94

EPS Next Y. (Est.)

25.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.37

Relative Volume

0.65

Return on Equity vs Sector %

-21.4

Return on Equity vs Industry %

-1.7

EPS 1 7Days Diff

-0.8

EPS 1 30Days Diff

-3.21

EBIT Estimation

846

◆ JAZZ Healthcare

$245.43

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

20/20

Pullback

6/25

Volume

6/15

Valuation

15/20

TP/AR

5/10

Options

7/10

RSI

66.5

Range 1M

99.9%

Sup Dist

3.2%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

23/25

Growth

22/30

Estimates

9/20

Inst/Vol

1/15

Options

6/10

EPS Yr

78.7%

EPS NY

77.7%

52W%

84%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +147.9% upside

Quality

9/30

Valuation

25/30

Growth

19/25

Stability

3/10

LT Trend

4/5

Upside

+147.9%

Quality

MoS

27%

JAZZ — P/E HistoricalBiotechnology

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2890

JAZZ

Latest News

—

Caricamento notizie per JAZZ…

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y